The underlying mechanism of coexistence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen antibody (anti-HBs) is still controversial. To identify the host genetic factors related to this unusual clinical phenomenon, a two-stage study was conducted in the Chinese Han population. In the first stage, we per- 
Summary
The underlying mechanism of coexistence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen antibody (anti-HBs) is still controversial. To identify the host genetic factors related to this unusual clinical phenomenon, a two-stage study was conducted in the Chinese Han population. In the first stage, we performed a case-control (1:1) age-and gender-matched study of 101 cases with concurrent HBsAg and anti-HBs and 102 controls with negative HBsAg and positive anti-HBs using whole exome sequencing. In the second validation stage, we directly sequence the 16 exons on the OAS3 gene in two dependent cohorts of 48 cases and 200 controls. Although, in the first stage, a genome-wide association study of 58,563 polymorphism variants in 101 cases and 102 controls found no significant loci (P-value ≤ .05/58563), and neither locus achieved a conservative genome-wide significance threshold (P-value ≤ 5e-08), gene-based burden analysis showed that OAS3 gene rare variants were associated with the coexistence of HBsAg and antiHBs. (P-value = 4.127e-06 ≤ 0.05/6994). A total of 16 rare variants were screened out from 21 cases and 3 controls. In the second validation stage, one case with a stop-gained rare variant was identified. Fisher's exact test of all 149 cases and 302 controls showed that the rare coding sequence mutations were more frequent in cases vs controls (P-value = 7.299e-09, OR = 17.27, 95% CI [5.01-58 .72]). Proteincoding rare variations on the OAS3 gene are associated with the coexistence of 
| MATERIAL S AND ME THODS
Methods S1.
| RE SULTS

| Characteristics of participants
The characteristics of the 203 subjects in the first stage are summarized in HBsAg and anti-HBs in patients with chronic HBV infection in Chinese Han population.
K E Y W O R D S
coexistence of HBsAg and anti-HBs, OAS3, rare variants, whole exome sequencing not only inactive carriers but also patients with chronic hepatitis B (CHB). A total of 26 patients in the case group were known used to take antiviral agents before the samples were collected.
| Genome-wide single-variant association study
We performed a genome-wide association study of 58 563 polymorphism variants with minor allele frequency >0.05 after QC filtered in 101 cases and 102 controls. Genetic association analysis was carried out with Fisher's exact test. No loci achieved a conservative significance threshold after Bonferroni correction for multiple testing (P-value ≤.05/58563) neither any locus achieved a conservative genome-wide significance threshold (P-value ≤5e-08). All variants with P-value are displayed in Figure S1 .
| Gene-based burden study
We evaluated whether cases were more likely to carry low-frequency were restrictive 0%-5% in control population, 0%-5% in ExAC-EAS database and 0%-5% in KG-EA database. Only the genes carried more than 5 variants were included into the panel for gene-based burden analysis. After filtering, the panel consists of 6994 genes which carried more than 5 low-frequency functional variants. Genebased burden analysis was carried out with weighted sum statistic method developed by Madsen and Browning. 15 All genes with Pvalue are displayed in Figure 1 . We found that OAS3 was achieved a conservative significance threshold after Bonferroni correction of 6994 genes testing (P-value = 4.127e-06 ≤ 0.05/6994). The variation distribution is shown in Figure S2 . A total of 16 rare variants (ExAC-EAS<0.01) with potentially functional variation on OAS3 gene were screened out (Table 2 ) and are distributed among 24 patients including 21 DP cases and 3 SP controls.
| The follow-up validation results
In the second stage, we sequenced and analysed the coding region of all 16 exons on OAS3 gene in two independent cohorts of 48 DP cases and 200 SP controls, respectively. The characteristics of the two cohorts are shown in Table 3 . After filtering the high-frequency variants, one DP case was found with a rare stop codon variation (ENST00000228928.7: c.3161G>A; p.1054Trp>Ter) on the OAS3
gene. (Figure 2) In total, 16 rare variants on the OAS3 gene were identified and distributed among 22 DP cases and 3 controls from the four cohorts.
A Fisher's exact test was then carried out among four cohorts combined together, that is, 149 DP cases and 302 SP controls. The result showed that DP case group has a significantly higher rate of rare variants than the SP controls. (P-value = 7.299e-09, OR = 17.27, 95% However, because of the difference of the study population including numbers, races, HBV genotypes, inclusion criteria and the sensitiv- Although, in the first stage of our study, genetic association analysis failed to find loci that would achieve a conservative genome-wide significance threshold after Bonferroni correction (P ≤ .05/58563), the results from gene-based burden analysis of rare variants showed OAS3
| D ISCUSS I ON
were achieved a conservative significance threshold after Bonferroni correction of 6994 genes testing (P ≤ .05/6994). This may be because:
first, GWAS usually does not have the power to detect all variants, only the ones with the biggest effects. Traditional GWAS mainly focused on the identification of common genetic variants by collecting them and then performing a series of single-marker tests where each variant is tested individually to discover associations. But only a small portion of disease heritability is explained by common variants, and studies consider that analyses of low-frequency (1%≤MAF<5%) and rare (MAF<1%) could explain additional disease risk or trait variability. As each rare variant is present in only a small number of individuals, single-marker tests have low power to identify these variants involved in complex disease. 25 Second, although next-generation deep sequencing provides an unparalleled opportunity to investigate the roles of low-frequency and rare variants in complex diseases, the statistical power of classical single-variant-based association tests for low-frequency and rare GWAS loci lie in noncoding regions. 26 The limitation that exome sequencing only captures genetic variation in the exome may also explain the failure to find significant loci using case-control association analysis. Accounting for these, a groupwise association tests that group rare variants in genes should be considered as methods to boost the power of studies on rare variants. Therefore, burden analysis is employed. It evaluates association for multiple variants in a biologically relevant region, such as a gene, instead of testing the effects of single variants, as is commonly done in GWAS, and eventually identifies OAS3 gene has a significant difference between the two groups.
15
Oligoadenylate synthetases (OAS) are pattern recognition receptors for viral dsRNA, a common pathogen-associated TA B L E 2 16 rare genetic variants found in the OAS3 gene in whole exome sequencing study 
Nucleotide numbering ("c.") reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence ENST00000228928.7 and ENST00000551007.1 (a). The initiation codon is codon 1. Protein numbering ("p.") refers to sequence ENSP00000228928.7 and ENSP00000449299.1 (b). "Chr" refers to chromosome, and "het" refers to heterozygous changes. ExAC-EAS refers to the East Asian population of ExAC (Exome Aggregation Consortium) data set. DP, double positive; SP, single positive. Therefore, deep whole genome sequencing should be considered in the future study.
Group
In this study, we demonstrate that OAS3 gene variants are associated with coexistence of HBsAg and anti-HBs in Chinese Han population through a burden study of rare variants and a subsequent validation study. Further functional study of OAS3 gene is needed to fully evaluate its contribution to CHB infection.
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